SUMMARY To determine whether a ventricular (LV) end-systolic dimension (ESD) > 55 mm and LV left fractional shortening < 25% are risk factors for aortic valve replacement (AVR) in patients with aortic insufficiency, we analyzed the clinical course and M-mode echocardiograms in 47 consecutive patients who underwent AVR for isolated symptomatic Al. Group 1 patients (n = 27) had a preoperative ESD < 55 mm (mean 44 mm, range 30-52 mm) and group 2 patients (n = 20) had a preoperative ESD > 55 mm (mean 62 mm, range 55-85 mm). One patient in group 1 and 10 patients in group 2 had left ventricular fractional shortening < 25%. There were no perioperative or postoperative deaths during an average follow-up of 41 months (range 6-76 months). Five patients had perioperative myocardial infarctions (MIs), three in group 1 and two in group 2. Since myocardial protection with cold potassium cardioplegia was instituted, no patient has suffered a perioperative MI. The average preoperative New York Heart Association functional classification was 2.3 (group 1) and 2.6 (group 2). Postoperatively, it was 1.2 in group 1 and 1.1 in group 2. Thirty-three patients (20 in group 1 and 13 in group 2) had echocardiograms at least 1 year after AVR. Of these, LV-end diastolic dimension decreased from 67 + 6 to 53 + 6 mm (mean ± SD) in group 1 (p < 0.001) and from 79 3 to 55 ± 6 mm in group 2 (p < 0.001). The LVESD also decreased, but this is difficult to interpret because offrequent postoperative abnormal interventricular septal motion. The LV cross-sectional area, an index of LV mass, decreased in group 1 from 25 ± 5 to 20 ± 5 cm2 (p < 0.001) and in group 2 from 32 ± 9 to 20 + 5 cm2 (p < 0.001). Postoperative end-diastolic dimension and cross-sectional area were not significantly different between the two groups. We concluded that in aortic insufficiency, a preoperative ESD 2, 55 mm does not preclude successful AVR, as judged by long-term survival, symptomatic relief, and normalization of LV dimensions assessed by echocardiography.
THE OPTIMAL management of patients with severe aortic insufficiency (Al) is still a matter of debate, especially in asymptomatic or minimally symptomatic patients.' The recommendation for aortic valve replacement (AVR) in these patients depends, among other factors,4 on the identification of the degree of left ventricular (LV) dysfunction beyond which the risks of perioperative and postoperative mortality and morbidity are increased. 5 Henry et al.6 used M-mode echocardiography to identify a population at high risk for AVR due to Al. In their experience, when the LV end-systolic dimension (ESD) was 55 mm or greater, AVR carried a higher risk of perioperative complications and postoperative death for congestive heart failure. Most of these patients had LV fractional shortening (FS) of less than 25% as well. Other studies have suggested that the end-systolic volume is an important predictor of the postoperative clinical course in patients after AVR for Al. 7 Other data do not support this,8 9 and we have seen several patients in this "high-risk" category with a benign peri-and postoperative course. We therefore performed a retrospective study to test the hypothesis that in patients with symptomatic Al, AVR is too late when the LV FS is less than 25% or ESD is 55 mm.
Methods Patients
From January 1972 to December 1980, 70 patients with symptomatic severe Al underwent isolated AVR at our institution. Patients were included in the study if they fulfilled the following criteria: chronic AI, absence of associated aortic stenosis (peak transvalvular gradient less than 20 mm Hg) or other valvular disease, absence of obstructive coronary artery disease and malfunction of the valve prosthesis. Only patients with a high-quality preoperative M-mode echocardiogram were included.
Clinical Studies
Forty-seven of the 70 patients met the criteria and were included in the study. All but one patient underwent preoperative right-and left-heart catheterization, including LV and aortic root cineangiography. In nine patients, angiographic quantification of LV volumes was impossible because the images were unsatisfactory. Selective coronary arteriography was performed in 34 patients: all of those older than age 40 years and in the younger patients with chest pain. Cardiac catheterization was performed within 3 months of surgery.
Echocardiograms were recorded with the patient in the supine or slight left lateral decubitus position using standard techniques.10 To minimize the variability in LV measurements due to body position, serial echocardiograms were obtained in the same position in both the pre-and postoperative studies.
The following echocardiographic measurements were performed: (1) Preoperataive vs Postoperative Echocardiographic Evaluation Echocardiographic data for the five patients suffering a perioperative MI were not included in the analysis of the other patients so as not to obscure the independent role of preoperative LV dimensions on postoperative results.
In 36 out of the 42 patients without perioperative MI, a good-quality echocardiogram was performed in the "early" postoperative period (average 3 months, range 2-6 months). Of these, 21 were in group 1 and 15 in group 2 (table 3). In both groups, EDD decreased significantly after AVR. Both preoperative and postoperative EDDs were significantly higher in group 2 than in group 1. In 33 patients, "late" postoperative echocardiograms (mean 39 months, range 12-75 months) were performed. Late postoperative EDDs were compared in the two groups and were not statistically different (table 4) . This lack of significant difference in the late postoperative LV EDD may have been due to the lack of late postoperative echocardiograms in some patients with very large preoperative EDDs in group 2. However, all of these patients showed a sizable decrease in LV EDD at the early postoperative study (table 5) .
CSA, an index of LV mass, decreased significantly early after AVR and from preoperative to late after Values are mean ± SD. 
Discussion
If M-mode echocardiography allowed identification of a high-risk subgroup of syptomatic patients with Al, it could also be used to determine the timing for AVR in patients with asymptomatic Al. Henry et al. 6 demonstrated that a preoperative ESD ¢ 55 mm carried a significantly higher risk of perioperative death, myocardial damage or late death from congestive heart failure. An LV FS of less than 25% was an additional risk factor in these patients.
Our results do not support these findings. In our series, no patient died perioperatively or postoperatively and the number of patients and the duration of postoperative follow-up were similar to those in the study of Henry et al. 6 The 0% mortality in our series is probably a chance statistical variation. Such a variation must not be considered exceptional, as larger series of AVRs without perioperative deaths have been reported."3 Furthermore, of the 58 consecutive isolated AVRs for aortic stenosis, Al or a mixed lesion performed at our institution in 1981 (after the completion of the present study), EDD There is little doubt that cold potassium cardioplegia decreases the risk of perioperative myocardial damage.'3 14 Better myocardial preservation may explain the good results of AVR in our series. This is especially important in patients with hypertrophied ventricles, who have a higher risk of perioperative myocardial damage. None of the patients in the series reported by Henry et al.6 had surgery with cold potassium cardioplegia, while 46% of our patients did. Furthermore, our patients were operated upon more recently, and improved surgical techniques may have influenced the results. 1 5
The mechanism of perioperative MI is most likely ischemic damage, and hypertrophied ventricles are most vulnerable. 16 All five of our perioperative infarcts occurred in patients who underwent AVR before cold potassium cardioplegia was introduced, and this did not occur in any of our patients afterwards. This leads us to suggest that the outcome observed by Henry et al. was not only determined by irreversible LV damage, but could also have been influenced by some degree of perioperative damage, of which MI is clinically the easiest to detect. 10 The incidence of significant tricuspid stenosis in rheumatic heart disease has been estimated to be about 3-5% on the basis of data from autopsy and cardiac catheterization studies. 1' 12 The diagnosis of triscupid stenosis is important because undetected and uncorrected tricuspid stenosis increases operative morbidity and mortality of cardiac surgery for left-sided cardiac valvular disease and worsens the prognosis for those who survive. 13, 14 From Echocardiography, both M-mode and two-dimensional, is a simple noninvasive technique for visualizing the tricuspid valve. In this report, we review the value of echocardiography in detecting tricuspid stenosis in 100 patients with rheumatic heart disease.
Materials and Methods
We reviewed the records of 100 consecutive patients with rheumatic heart disease studied by cardiac catheterization and by echocardiography. All 100 patients underwent right-and left-sided cardiac catheterization and cardiac angiography. In all 100 patients, M-mode and two-dimensional echocardiography were performed before cardiac catheterization. Angiography was performed in the usual manner. 
